U.S. Capital Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.4M	Buy	157,263 +31,670	+25%	+$7.38M	0.97%	16
2025 Q4	$26M	Sell	125,593 -595	-0.5%	-$118K	0.68%	27
2025 Q3	$23.4M	Sell	126,188 -1,291	-1%	-$221K	0.63%	31
2025 Q2	$19.5M	Buy	127,479 +4,521	+4%	+$695K	0.57%	35
2025 Q1	$20.4M	Buy	122,958 +7,756	+7%	+$1.21M	0.62%	30
2024 Q4	$16.7M	Sell	115,202 -4,389	-4%	-$680K	0.52%	38
2024 Q3	$19.4M	Sell	119,591 -6,224	-5%	-$992K	0.68%	23
2024 Q2	$18.4M	Buy	125,815 +3,007	+2%	+$447K	0.7%	23
2024 Q1	$19.4M	Sell	122,808 -14,056	-10%	-$2.24M	0.75%	25
2023 Q4	$21.5M	Buy	136,864 +1,001	+0.7%	+$153K	0.85%	18
2023 Q3	$21.2M	Buy	135,863 +5,877	+5%	+$970K	0.95%	16
2023 Q2	$21.5M	Buy	129,986 +7,782	+6%	+$1.26M	1.02%	16
2023 Q1	$18.9M	Buy	122,204 +5,488	+5%	+$886K	0.88%	18
2022 Q4	$20.6M	Buy	116,716 +1,662	+1%	+$287K	0.96%	12
2022 Q3	$18.8M	Buy	115,054 +3,034	+3%	+$513K	0.95%	13
2022 Q2	$19.9M	Buy	112,020 +1,328	+1%	+$237K	0.87%	18
2022 Q1	$19.6M	Buy	110,692 +5,163	+5%	+$879K	0.72%	20
2021 Q4	$18.1M	Buy	105,529 +11,011	+12%	+$1.8M	0.72%	22
2021 Q3	$15.3M	Buy	+94,518	New	+$16.1M	0.66%	28

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Capital Wealth Advisors's JNJ Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 25% in Q1 2026, buying an estimated $7.38M and bringing the position to 157,263 shares worth $38.4M. The position accounts for 0.97% of the portfolio, ranked #16.

U.S. Capital Wealth Advisors first reported a position in JNJ in Q3 2021 and has held it in 19 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

U.S. Capital Wealth Advisors held 157,263 shares of Johnson & Johnson worth $38.4M as of Q1 2026.
U.S. Capital Wealth Advisors bought 31,670 Johnson & Johnson shares in Q1 2026, an estimated $7.38M.
Johnson & Johnson made up 0.97% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #16 holding.
U.S. Capital Wealth Advisors first reported a position in Johnson & Johnson in Q3 2021 and has held it in 19 quarters since.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.